Gaquing, Dolores S.
HRN: 12-76-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
CEFTRIAXONE 1G (VIAL)
07/01/2026
07/07/2026
IV
2g
Q24
Cap MR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: